Login / Signup

Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature Review.

Ruei-Lin WangWen-Fang ChiangChih-Chiun ChiuKuo-An WuChia-Yi LinYung-Hsi KaoChin-Pin ChuuJenq-Shyong ChanPo-Jen Hsiao
Published in: Vaccines (2022)
We report a case of "COVID arm": a localized erythematous rash surrounding the injection site that arose three days after the first dose of the Moderna COVID-19 vaccine. Delayed injection site reactions occurred in approximately 0.8% of vaccinated people after the first dose and in approximately 0.2% after the second dose. The lesions persisted for several days and then resolved without treatment. Health care providers were not prepared to address these delayed local reactions to the mRNA-1273 vaccine. Given the scale-up of mass vaccination campaigns worldwide, these skin reactions may likely generate concerns among patients and requests for evaluation. Although these skin reactions have not been consistently recognized, guidance regarding the second dose of the vaccine has varied, and many patients have unnecessarily received antibiotic agents.
Keyphrases
  • coronavirus disease
  • sars cov
  • healthcare
  • soft tissue
  • end stage renal disease
  • newly diagnosed
  • wound healing
  • ejection fraction
  • chronic kidney disease
  • social media
  • smoking cessation
  • patient reported